Romania · Delayed Price · Currency is RON Ceprohart Statistics
Total Valuation
Ceprohart has a market cap or net worth of RON 5.02 million. The enterprise value is 5.05 million.
| Market Cap | 5.02M |
| Enterprise Value | 5.05M |
Important Dates
The next confirmed earnings date is Monday, September 28, 2026.
| Earnings Date | Sep 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Ceprohart has 278,939 shares outstanding.
| Current Share Class | 278,939 |
| Shares Outstanding | 278,939 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 194,554 |
Valuation Ratios
The trailing PE ratio is 94.54.
| PE Ratio | 94.54 |
| Forward PE | n/a |
| PS Ratio | 1.12 |
| PB Ratio | 0.95 |
| P/TBV Ratio | 0.95 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 95.11 |
| EV / Sales | 1.12 |
| EV / EBITDA | 15.99 |
| EV / EBIT | 40.35 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.95, with a Debt / Equity ratio of 0.30.
| Current Ratio | 4.95 |
| Quick Ratio | 0.71 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | 4.98 |
| Debt / FCF | n/a |
| Interest Coverage | 1.98 |
Financial Efficiency
Return on equity (ROE) is 1.01% and return on invested capital (ROIC) is 1.64%.
| Return on Equity (ROE) | 1.01% |
| Return on Assets (ROA) | 1.07% |
| Return on Invested Capital (ROIC) | 1.64% |
| Return on Capital Employed (ROCE) | 1.82% |
| Weighted Average Cost of Capital (WACC) | 4.17% |
| Revenue Per Employee | 95,645 |
| Profits Per Employee | 1,130 |
| Employee Count | 47 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 0.99 |
Taxes
In the past 12 months, Ceprohart has paid 6,785 in taxes.
| Income Tax | 6,785 |
| Effective Tax Rate | 11.33% |
Stock Price Statistics
The stock price has decreased by -7.22% in the last 52 weeks. The beta is 0.02, so Ceprohart's price volatility has been lower than the market average.
| Beta (5Y) | 0.02 |
| 52-Week Price Change | -7.22% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 91 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ceprohart had revenue of RON 4.50 million and earned 53,110 in profits. Earnings per share was 0.19.
| Revenue | 4.50M |
| Gross Profit | 1.34M |
| Operating Income | 125,190 |
| Pretax Income | 59,895 |
| Net Income | 53,110 |
| EBITDA | 315,813 |
| EBIT | 125,190 |
| Earnings Per Share (EPS) | 0.19 |
Balance Sheet
The company has 106,482 in cash and 1.57 million in debt, with a net cash position of -1.47 million or -5.26 per share.
| Cash & Cash Equivalents | 106,482 |
| Total Debt | 1.57M |
| Net Cash | -1.47M |
| Net Cash Per Share | -5.26 |
| Equity (Book Value) | 5.31M |
| Book Value Per Share | 19.02 |
| Working Capital | 3.55M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 190,623 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 29.86%, with operating and profit margins of 2.78% and 1.18%.
| Gross Margin | 29.86% |
| Operating Margin | 2.78% |
| Pretax Margin | 1.33% |
| Profit Margin | 1.18% |
| EBITDA Margin | 7.03% |
| EBIT Margin | 2.78% |
| FCF Margin | n/a |
Dividends & Yields
Ceprohart does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 1.06% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ceprohart has an Altman Z-Score of 2.34 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.34 |
| Piotroski F-Score | 3 |